Prothrombotic Gene Polymorphisms in Young Patients with Cerebrovascular Accident

被引:1
作者
Ozturk, Kuyas Hekimler [1 ]
Ozgaz, Asuman [1 ]
Icduygu, Fadime Mutlu [1 ]
Soysal, Yasemin [1 ]
Kusbeci, Ozge Yilmaz [2 ]
Imirzalioglu, Necat [1 ]
机构
[1] Afyon Kocatepe Univ, Tip Fak, Tibbi Genet AD, Ali Cetinkaya Kampusu, TR-03200 Afyon, Turkey
[2] Afyon Kocatepe Univ, Tip Fak, Norol AD, Afyon, Turkey
关键词
Cerebrovascular Accident; Genetic Polymorphisms; Methylenetetrahydrofolate Reductase;
D O I
10.4328/JCAM.1024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: Cerebrovascular diseases are complex multifactorial disorders showing an increased incidence with increasing age and affected by genetic and environmental factors. Although risk factors for cerebrovascular diseases include age, sex, lineage, hypertension, diabetes mellitus, hypercholesterolemia; in young cerebrovascular patients below age 45, genetic factors may also contribute to the etiology. In this retrospective study, prothrombotic gene polymorphisms which are thought to be related with formation of disease in young adults with cerebrovascular accident (CVA) were investigated. Material and Method: In the current study, Methylenetetrahydropholate Reductase (MTHFR) C677T and A129C; Prothrombin (Factor II) G20210A; Factor V Leiden G1691A prothrombotic gene polymorphisms were evaluated for 43 young patients under the age of 45 with cerebrovascular accident history. Result: For 43 young patients with cerebrovascular incident history, the frequency of following polymorphisms were determined as follows; MTHFR C677T polymorphism heterozygous frequency is 46.1%, homozygous frequency is 9.3%; MTHFR A1298C polymorphism heterozygous frequency is 39.47%, homozygous frequency is 26.31%; Prothrombin polymorphism heterozygous and homozygous frequency is 2.3%; FactorV Leiden polymorphism heterozygous frequency is 9.3%. Discussion: After evaluation the experimental results, we believe that MTHFR gene C677T and A1298C polymorphisms might be risk factors in CVAs. It was observed that cigarette usage, hypertension and existence of family story in addition to these polymorphisms increase the available risk.
引用
收藏
页码:273 / 276
页数:4
相关论文
共 24 条
  • [1] AKAR N, 1997, J THROMB HAEMOST, V78, P1527
  • [2] Albucher JF, 1996, STROKE, V27, P766
  • [3] Bakar E., 2009, GULHANE TIP DERG, V51, P177
  • [4] Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss
    Carp, H
    Salomon, O
    Seidman, D
    Dardik, R
    Rosenberg, N
    Inbal, A
    [J]. HUMAN REPRODUCTION, 2002, 17 (06) : 1633 - 1637
  • [5] Lower contribution of factor V Leiden or G202104 mutations to ischemic stroke in patients with clinical risk factors: Pair-matched case-control study
    Eterovic, Davor
    Titlic, Marina
    Culic, Viktor
    Zadro, Renata
    Primorac, Dragan
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2007, 13 (02) : 188 - 193
  • [6] Friedline JA, 2001, ARCH PATHOL LAB MED, V125, P105
  • [7] A common mutation A1298C in human methylenetetrahydrofolate reductase gene: Association with plasma total homocysteine and folate concentrations
    Friedman, G
    Goldschmidt, N
    Friedlander, Y
    Ben-Yehuda, A
    Selhub, J
    Babaey, S
    Mendel, M
    Kidron, M
    Bar-On, H
    [J]. JOURNAL OF NUTRITION, 1999, 129 (09) : 1656 - 1661
  • [8] A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE
    FROSST, P
    BLOM, HJ
    MILOS, R
    GOYETTE, P
    SHEPPARD, CA
    MATTHEWS, RG
    BOERS, GJH
    DENHEIJER, M
    KLUIJTMANS, LAJ
    VANDENHEUVEL, LP
    ROZEN, R
    [J]. NATURE GENETICS, 1995, 10 (01) : 111 - 113
  • [9] Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia
    Junker, R
    Koch, HG
    Auberger, K
    Münchow, N
    Ehrenforth, S
    Nowak-Göttl, U
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (10) : 2568 - 2572
  • [10] Kluijtmans LAJ, 1996, AM J HUM GENET, V58, P35